Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
100 participants
INTERVENTIONAL
2019-08-25
2022-04-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The investigators will do that by doing a prospective comparative study on patients presented to our department by bilaterally obstructed kidneys , by either benign or malignant causes , with high serum chemistry. Intervention to this cases will be done by inserting JJ or PCN either unilateral or bilateral depending upon lab workups , our staff decision and patients fittness and agreement .
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Percutaneous Nephrolithotomy in Patients With Stage 2-4 Chronic Kidney Disease
NCT04943081
Effect of Per-cutaneous Nephrosotomy Drainage on Radioisotope Imaging of Hydronephrotic Kidneys
NCT03695991
Diagnosis of Acute Obstructive Renal Failure by Clinical Ultrasound Performed by the Emergency Physician.
NCT06190522
Non Diabetic Causes of Chronic Kidney Disease in Type 2 Diabetic Patients
NCT05021705
Changes Post Percutaneous Nephrolithotomy
NCT06185387
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
There has been always a debate about which one is better to drain the obstructed kidneys percutaneous nephrostomy or ureteric stents and which is better in improvement of renal function and with less effect on life style . Also the mode of drainage of the obstructed kidneys, bilateral or unilateral, also has been a point of debate. Unless bilateral renal obstruction is due to benign or treatable malignant cause, unilateral nephrostomy is always the rule according to some authors . some authors, reported better improvement in renal function with bilateral PCN with pelvic tumors The investigators will do prospective comparative study for studying mode and laterality of drainage in benign and malignant causes in bilaterally obstructed kidneys .
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
CROSSOVER
SCREENING
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Bilaterally Obstructed Kidneys by benign cause
unilateral drainage of Bilaterally Obstructed Kidneys
drainage of obsructed kidneys by PCN or jj
bilateral drainage of Bilaterally Obstructed Kidneys
drainage of obsructed kidneys by PCN or jj
Bilaterally Obstructed Kidneys by malignant cause
unilateral drainage of Bilaterally Obstructed Kidneys
drainage of obsructed kidneys by PCN or jj
bilateral drainage of Bilaterally Obstructed Kidneys
drainage of obsructed kidneys by PCN or jj
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
unilateral drainage of Bilaterally Obstructed Kidneys
drainage of obsructed kidneys by PCN or jj
bilateral drainage of Bilaterally Obstructed Kidneys
drainage of obsructed kidneys by PCN or jj
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. Bilateral obstructed kidneys due to benign causes
3. Bilateral obstructed kidneys due to malignant causes
4. Bilateral obstructed kidneys with high serum creatinine
Exclusion Criteria
2. Bilateral obstructed kidneys with normal serum creatinine
3. patients with chronic kidney disease
4. Vesicoureteric reflux
5. Severe comorbidity preventing intervention
12 Months
3 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Assiut University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Ahmed Mahmoud Abdelraouf
Resident at Urology Hospital at Assiut University
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Drainage of BOK In B or M
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.